Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia

Submitted: July 31, 2021
Accepted: March 24, 2022
Published: April 12, 2022
Abstract Views: 1095
PDF: 403
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Diabetics who develop severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) are more likely to have severe disease, higher odds of intensive care requirement and mortality. Fifteen percent of patients have new onset hyperglycemia. We studied the comparative outcomes between prior DM, newly detected hyperglycemia and assessed role of secondary sepsis on mortality. RWe performed a r etrospective study of confirmed SARS-CoV-2 patients at a tertiary care hospital in Chennai, India. Patients were divided as 2 groups (Group 1: With preexisting diabetes mellitus, Group 2: With newly diagnosed hyperglycemia due to newly detected diabetes mellitus or non-diabetic hyperglycemia. Clinical and laboratory data was analysed. Two hundred and thirty eight patients had prior-diabetes mellitus (Group 1) and 40 had newly diagnosed hyperglycemia (Group 2). Thirty four of group 1 and 7 of group 2 patients required intensive care. Mean capillary blood glucose (MCBG) during hospital stay was 207 mg/dl (Group 1) and 192 mg/dl (Group 2). Twentysix patients (9.3%) had secondary sepsis of which sixteen died. Logistic regression identified secondary sepsis(p<0.0001), elevated D-dimer >6 fold (p= 0.0001), elderly p=0.0045), male (p=0.0006), NLR >5 (p=0.01),serum creatinine ≥2 mg/dl (p=0.0004), FiO2 requirement >0.6 in first 48 hours (p=0.001) as mortality predictors.Our study observed a 14.38 % prevalence of newly diagnosed DM or non-diabetic hyperglycemia. Secondary sepsis and >6 fold elevation in D-dimer were strong predictors of mortality. Steroid use possibly contributed to secondary sepsis. Early identification and aggressive management of secondary sepsis are necessary for diabetics.



PlumX Metrics


Download data is not yet available.


International Diabetes Federation. IDF Diabetes atlas. 2020. accessed on 25-12-202. Available from:
Knapp Sa. Diabetes and infection: is there a link? A mini review. Gerontology 2013;59:99-104.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42.
Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short term outcome. J Clin Virol Jun 2020;127:104354.
Hu L, Chen S, Fu Y, et al. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China. Clin Infect Dis 2020;71:2089-98.
Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J 2020;55:2000547.
Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract 2020;164:108166.
Yang J-K, Lin S-S, X-J Ji, L-M Guo. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. ActaDiabetol 2020;47:193-9.
Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7.
Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract 2020;162:108-18.
Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes. Diabet Care 2019;42:S13–28.
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91-5.
Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res Clin Pract 2020;162:108125.
Dunn EJ, Grant PJ. Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med 2005;5:323-32.
Sathish T, Kapoor N, Cao Y, et al. Proportion of newly diagnosed diabetes in COVID19 patients: a systematic review and metaanalysis. Diabetes Obes Metab 2021;23:870-4.
Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab 2021;47:101204.
Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82.
Li H,Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020;22:1897-906.
RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. N Engl J Med 2021;384:693-704.
Alessi J, de Oliveira GB, Schaan BD, et al. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. Diabetol Metab Syndr 2020;12:80.
De Micheli A. [Corticosteroid induced diabetes mellitus: diagnosis and management].[Article in Italian]. G Ital Nefrol 2016 Malattie Metaboliche e Rene;33(S68):gin/33.S68.7.
Yang Z, Liu J, Zhou Y, et al. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect 2020;81:e13-20.
Caughey GE, Preiss AK, Vitry AI, et al. Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications. Diab Care 2013;36:3009–14.
Lieber B, Han B, Strom RG, et al. Preoperative predictors of spinal infection within the national surgical quality inpatient database. World Neurosurg 2016;89:517-24.
Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and ostoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008; 248:585–91.
Venkatesh B, Finfer S, Cohen J, et al. adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018;378:797-808.
Palaiodimos L, Chamorro-Pareja N, Karamanis D, et al. Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Hormones (Athens) 2021;20:305-14.
Shi Q, Zhang X, Jiang F. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective case-control study. Diabetes Care 2020;43:1382-91.
Holman N, Knighton P, Kar P, et al. Risk factors for covid related mortality in people with type 1 and type 2 diabetes in England. A population based cohort study. Lancet Diab Endocrin 2020;8:822-33.
Langford BJ, Miranda So, Raybardhan S, et al. Bacterial coinfection and secondary infection in patients with Covid 19: a living rapid review and meta analysis. Clin Microbiol Infect 2020;26:1622-29.
Li J, Wang J, Yang Y, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control 2020;9:153.
Rajeev Soman, Ayesha Sunavala. Post Covid 19 mucormycosis - from the frying pan into the fire. J Assoc Physicians India 2021;69:13-14.
Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 2020;18:1324-9.
Mejia F, Medina C, Cornejo E, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One 2020;15:e0244171.

How to Cite

Nair, Aiswarya M, Sowmya Gopalan, Vaasanthi Rajendran, Priyadarshini Varadaraj, Lakshmi Marappa, Viswanathan Pandurangan, Sudha Madhavan, Rajkumar Mani, and Emmanuel Bhaskar. 2022. “Role of Secondary Sepsis in COVID-19 Mortality: Observations on Patients With Preexisting Diabetes Mellitus and Newly Diagnosed Hyperglycemia”. Monaldi Archives for Chest Disease 92 (4).